Second Quarter 2025 Results Key Financial Results Revenue: US$1.08b (up 21% from 2Q 2024).

Second Quarter 2025 Results Key Financial Results Revenue: US$185.5m (up 28% from ...

Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

Q2 2025 Earnings Call Transcript August 1, 2025 IRadimed Corporation reports earnings inline with expectations. Reported EPS ...

Key Points Earnings per share (GAAP) in Q2 2025 exceeded expectations, rising to $1.68 versus the analyst estimate of $1.47, and increasing 265.2% year-over-year. Net interest income on a fully ...

Q2 2025 Earnings Call Transcript August 1, 2025 Fortis Inc. beats earnings expectations. Reported EPS is $0.558, expectations ...

Management reaffirmed 2025 operating earnings per share guidance of $3.28 to $3.52, with a midpoint of $3.40. Ridge stated, "I'm highly confident in our ability to deliver on our financial plan, ...

Praxis Precision Medicine PRAX -4.09% Get Free Report will release its quarterly earnings report on Monday, 2025-08-04. Here's a brief overview for investors ahead of the announcement. Analysts ...

Consider selling overvalued United Breweries Ltd stock due to stretched valuations, limited pricing power, and modest margins ...

Analysts are estimating that Castle Biosciences will report an earnings per share (EPS) of $-0.50. Investors in Castle Biosciences are eagerly awaiting the company's announcement, hoping for news of ...

Operator: Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.

Bank of Hawaii is positioned well amid economic uncertainty. BOH stock trades at a discount to past average multiples. Read ...